Cardiology on the cutting edge: updates from the European Society of Cardiology (ESC) Congress 2020

被引:0
作者
Enrique Gallego-Colon
Aldo Bonaventura
Alessandra Vecchié
Antonio Cannatà
Ciarán Martin Fitzpatrick
机构
[1] Barzilai University Medical Center,Cardiology Department
[2] Virginia Commonwealth University,Pauley Heart Center, Division of Cardiology, Department of Internal Medicine
[3] University of Genoa,First Clinic of Internal Medicine, Department of Internal Medicine
[4] King’s College London,Department of Cardiovascular Sciences, Faculty of Life Sciences and Medicine
[5] Azienda Sanitaria Universitaria Integrata Di Trieste and University of Trieste,Cardiovascular Department
[6] BMC Series,undefined
来源
BMC Cardiovascular Disorders | / 20卷
关键词
ESC Congress; ESC guidelines; Heart failure; Hypertension; Myocardial infarction; Pulmonary embolism; Atrial fibrillation; COVID-19;
D O I
暂无
中图分类号
学科分类号
摘要
The 2020 annual Congress of the European Society of Cardiology (ESC) was the first ever to be held virtually. Under the spotlight of ‘the cutting edge of cardiology’, exciting and ground-breaking cardiovascular (CV) science was presented both in basic and clinical research. This commentary summarizes essential updates from ESC 2020—The Digital Experience. Despite the challenges that coronavirus disease 2019 (COVID-19) has posed on the conduct of clinical trials, the ESC Congress launched the results of major studies bringing innovation to the field of general cardiology, cardiac surgery, heart failure, interventional cardiology, and atrial fibrillation. In addition to three new ESC guidelines updates, the first ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease were presented. As former ESC president, Professor Casadei undoubtedly pointed out the ESC Congress 2020 was a great success. During the ESC 2020 Congress, BMC Cardiovascular Disorders updated to seven journal sections including Arrhythmias and Electrophysiology, CV Surgery, Coronary Artery Disease, Epidemiology and Digital health, Hypertension and Vascular biology, Primary prevention and CV Risk, and Structural Diseases, Heart Failure, and Congenital Disorders. To conclude, an important take-home message for all CV health care professionals engaged in the COVID-19 pandemic is that we must foresee and be prepared to tackle the dramatic, long-term CV complications of COVID-19 patients.
引用
收藏
相关论文
共 227 条
[1]  
Casadei B(2020)Barbara Casadei opening at virtual ESC Annual Congress 2020 Eur Heart J 41 3122-3123
[2]  
Driggin E(2020)Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic J Am Coll Cardiol 75 2352-2371
[3]  
Madhavan MV(2020)Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy N Engl J Med 383 88-89
[4]  
Bikdeli B(2020)Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era Eur Heart J 41 2083-2088
[5]  
Chuich T(2020)Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic J Am Coll Cardiol 75 2871-2872
[6]  
Laracy J(2020)Temporal trends in decompensated heart failure and outcomes during COVID-19: a multisite report from heart failure referral centres in London Eur J Heart Fail 75 359-367
[7]  
Biondi-Zoccai G(2020)Cardiovascular considerations in treating patients with coronavirus disease 2019 (COVID-19) J Cardiovasc Pharmacol 396 759-769
[8]  
Brown TS(2020)2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) Eur Heart J 381 1995-2008
[9]  
Der Nigoghossian C(2020)2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 61 404-410
[10]  
Zidar DA(2020)2020 ESC Guidelines for the management of adult congenital heart disease Eur Heart J 381 2497-2505